Celldex Therapeutics (CLDX) Revenue & Revenue Breakdown
Celldex Therapeutics Revenue Highlights
Latest Revenue (Y)
$6.88M
Latest Revenue (Q)
$156.00K
Main Segment (Y)
Grant
Main Geography (Y)
Grant
Celldex Therapeutics Revenue by Period
Celldex Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $6.88M | 192.02% |
| 2022-12-31 | $2.36M | -49.32% |
| 2021-12-31 | $4.65M | -37.30% |
| 2020-12-31 | $7.42M | 107.61% |
| 2019-12-31 | $3.57M | -62.54% |
| 2018-12-31 | $9.54M | -25.15% |
| 2017-12-31 | $12.74M | 87.78% |
| 2016-12-31 | $6.79M | 23.83% |
| 2015-12-31 | $5.48M | 52.82% |
| 2014-12-31 | $3.59M | -12.77% |
| 2013-12-31 | $4.11M | -63.30% |
| 2012-12-31 | $11.20M | 20.91% |
| 2011-12-31 | $9.27M | -80.20% |
| 2010-12-31 | $46.79M | 208.25% |
| 2009-12-31 | $15.18M | 103.61% |
| 2008-12-31 | $7.46M | 46.10% |
| 2007-12-31 | $5.10M | 3.48% |
| 2006-12-31 | $4.93M | 59.67% |
| 2005-12-31 | $3.09M | -54.97% |
| 2004-12-31 | $6.86M | 48.04% |
| 2003-12-31 | $4.63M | -30.90% |
| 2002-12-31 | $6.70M | 100.39% |
| 2001-12-31 | $3.35M | 338.40% |
| 2000-12-31 | $763.20K | -48.55% |
| 1999-12-31 | $1.48M | -32.57% |
| 1998-12-31 | $2.20M | 83.33% |
| 1997-12-31 | $1.20M | 9.09% |
| 1996-12-31 | $1.10M | -72.50% |
| 1995-12-31 | $4.00M | -42.86% |
| 1994-12-31 | $7.00M | -22.22% |
| 1993-12-31 | $9.00M | - |
Celldex Therapeutics generated $6.88M in revenue during NA 2023, up 192.02% compared to the previous quarter, and up 72.16% compared to the same period a year ago.
Celldex Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $156.00K | -96.22% |
| 2023-12-31 | $4.13M | 172.31% |
| 2023-09-30 | $1.52M | 466.04% |
| 2023-06-30 | $268.00K | -72.29% |
| 2023-03-31 | $967.00K | -40.05% |
| 2022-12-31 | $1.61M | 296.31% |
| 2022-09-30 | $407.00K | 149.69% |
| 2022-06-30 | $163.00K | -6.32% |
| 2022-03-31 | $174.00K | -47.75% |
| 2021-12-31 | $333.00K | 117.65% |
| 2021-09-30 | $153.00K | -95.60% |
| 2021-06-30 | $3.48M | 408.03% |
| 2021-03-31 | $685.00K | -81.91% |
| 2020-12-31 | $3.79M | 466.77% |
| 2020-09-30 | $668.00K | 183.05% |
| 2020-06-30 | $236.00K | -91.35% |
| 2020-03-31 | $2.73M | 207.55% |
| 2019-12-31 | $887.00K | 62.45% |
| 2019-09-30 | $546.00K | -23.64% |
| 2019-06-30 | $715.00K | -49.82% |
| 2019-03-31 | $1.43M | -19.22% |
| 2018-12-31 | $1.76M | 87.46% |
| 2018-09-30 | $941.00K | -65.94% |
| 2018-06-30 | $2.76M | -32.08% |
| 2018-03-31 | $4.07M | 17.71% |
| 2017-12-31 | $3.46M | -11.93% |
| 2017-09-30 | $3.92M | 2.48% |
| 2017-06-30 | $3.83M | 149.61% |
| 2017-03-31 | $1.53M | -18.14% |
| 2016-12-31 | $1.87M | -15.59% |
| 2016-09-30 | $2.22M | 59.83% |
| 2016-06-30 | $1.39M | 6.60% |
| 2016-03-31 | $1.30M | -27.25% |
| 2015-12-31 | $1.79M | 74.56% |
| 2015-09-30 | $1.03M | -52.89% |
| 2015-06-30 | $2.18M | 348.15% |
| 2015-03-31 | $486.00K | -67.10% |
| 2014-12-31 | $1.48M | 34.15% |
| 2014-09-30 | $1.10M | 85.98% |
| 2014-06-30 | $592.00K | 42.31% |
| 2014-03-31 | $416.00K | -32.90% |
| 2013-12-31 | $620.00K | -36.73% |
| 2013-09-30 | $980.00K | 910.31% |
| 2013-06-30 | $97.00K | -95.98% |
| 2013-03-31 | $2.41M | -33.81% |
| 2012-12-31 | $3.65M | 17.15% |
| 2012-09-30 | $3.11M | 54.95% |
| 2012-06-30 | $2.01M | -17.43% |
| 2012-03-31 | $2.43M | -0.04% |
| 2011-12-31 | $2.43M | 3.00% |
| 2011-09-30 | $2.36M | 21.06% |
| 2011-06-30 | $1.95M | -22.42% |
| 2011-03-31 | $2.52M | -93.33% |
| 2010-12-31 | $37.72M | 1466.49% |
| 2010-09-30 | $2.41M | -18.40% |
| 2010-06-30 | $2.95M | -20.52% |
| 2010-03-31 | $3.71M | -21.55% |
| 2009-12-31 | $4.73M | 17.44% |
| 2009-09-30 | $4.03M | 50.09% |
| 2009-06-30 | $2.69M | -28.05% |
| 2009-03-31 | $3.73M | 24.87% |
| 2008-12-31 | $2.99M | 26.73% |
| 2008-09-30 | $2.36M | 20.21% |
| 2008-06-30 | $1.96M | 1230.83% |
| 2008-03-31 | $147.40K | -91.43% |
| 2007-12-31 | $1.72M | - |
Celldex Therapeutics generated $156.00K in revenue during Q1 2024, up -96.22% compared to the previous quarter, and up 9.67% compared to the same period a year ago.
Celldex Therapeutics Revenue Breakdown
Celldex Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Grant | $6.61M | $2.30M | $5.12M | $3.10M | - |
| Service | $278.00K | $56.00K | $2.30M | $473.00K | - |
| Contracts and grants | - | - | $4.62M | - | - |
| Product development and licensing agreements | - | - | $31.00K | - | - |
Celldex Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant (95.96%), and Service (4.04%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $2.00K | $262.00K | $16.00K | $26.00K | - | $26.00K | $3.00K | $4.00K | $12.00K | $-1.00K | $2.29M | $94.00K | $55.00K | $195.00K | $129.00K | - | - | - | - | - |
| Grant | $154.00K | $5.39M | $252.00K | $967.00K | $1.59M | $153.00K | $3.45M | $682.00K | $3.78M | $656.00K | $236.00K | $442.00K | $793.00K | $491.00K | $520.00K | $1.30M | - | - | - | - |
| Contracts and grants | - | - | - | - | - | $407.00K | $163.00K | $144.00K | $332.00K | - | - | - | - | - | - | - | - | - | - | - |
| Product development and licensing agreements | - | - | - | - | - | - | - | $30.00K | $2.00K | - | - | - | - | - | - | - | - | - | - | - |
Celldex Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Grant (98.72%), and Service (1.28%).
Celldex Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Grant | $2.30M | $5.12M | $3.10M | $6.20M | - |
| Service | $56.00K | $2.30M | $473.00K | $3.34M | - |
| Product development and licensing agreements | - | $31.00K | - | - | - |
| Contracts and grants | - | $4.62M | - | - | - |
Celldex Therapeutics's latest annual revenue breakdown by geography, as of Dec 22: Grant (97.62%), and Service (2.38%).
Celldex Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TVTX | Travere Therapeutics | $145.24M | $54.12M |
| IMTX | Immatics | $54.00M | $30.45M |
| IDYA | IDEAYA Biosciences | $23.39M | - |
| ANAB | AnaptysBio | $17.16M | $10.97M |
| MGTX | MeiraGTx | $14.02M | $282.00K |
| RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
| RNA | Avidity Biosciences | $9.56M | $2.04M |
| CYTK | Cytokinetics | $7.53M | $249.00K |
| CLDX | Celldex Therapeutics | $6.88M | $156.00K |
| SWTX | SpringWorks Therapeutics | $5.45M | $21.01M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| FIXX | Q32 Bio | $1.16M | - |
| KRTX | Karuna Therapeutics | $654.00K | - |
| KROS | Keros Therapeutics | $151.00K | $83.00K |
| ALXO | ALX Oncology | - | - |
| COGT | Cogent Biosciences | - | - |
| BCAB | BioAtla | - | - |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| AVTE | Aerovate Therapeutics | - | - |
| DICE | DICE Therapeutics | - | - |
| DYN | Dyne Therapeutics | - | - |
| CERE | Cerevel Therapeutics | - | - |
| VTYX | Ventyx Biosciences | - | - |
| EWTX | Edgewise Therapeutics | - | - |
CLDX Revenue FAQ
What is Celldex Therapeutics’s yearly revenue?
Celldex Therapeutics's yearly revenue for 2023 was $6.88M, representing an increase of 192.02% compared to 2022. The company's yearly revenue for 2022 was $2.36M, representing a decrease of -49.32% compared to 2021. CLDX's yearly revenue for 2021 was $4.65M, representing a decrease of -37.30% compared to 2020.
What is Celldex Therapeutics’s quarterly revenue?
Celldex Therapeutics's quarterly revenue for Q1 2024 was $156K, a -96.22% decrease from the previous quarter (Q4 2023), and a -83.87% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $4.13M, a 172.31% increase from the previous quarter (Q3 2023), and a 156.11% increase year-over-year (Q4 2022). CLDX's quarterly revenue for Q3 2023 was $1.52M, a 466.04% increase from the previous quarter (Q2 2023), and a 272.73% increase year-over-year (Q3 2022).
What is Celldex Therapeutics’s revenue growth rate?
Celldex Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 47.99%, and for the last 5 years (2019-2023) was 92.64%.
What are Celldex Therapeutics’s revenue streams?
Celldex Therapeutics's revenue streams in c 23 are Grant, and Service. Grant generated $6.6M in revenue, accounting 95.96% of the company's total revenue, up 187.05% year-over-year. Service generated $278K in revenue, accounting 4.04% of the company's total revenue, up 396.43% year-over-year.
What is Celldex Therapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Celldex Therapeutics was Grant. This segment made a revenue of $6.6M, representing 95.96% of the company's total revenue.